Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat5a
|
ENSMUSG00000004043.8 | signal transducer and activator of transcription 5A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_100870468_100870632 | Stat5a | 8469 | 0.134366 | -0.85 | 3.2e-02 | Click! |
chr11_100870303_100870455 | Stat5a | 8640 | 0.133949 | -0.84 | 3.7e-02 | Click! |
chr11_100860080_100860281 | Stat5a | 165 | 0.930888 | -0.83 | 4.1e-02 | Click! |
chr11_100859328_100859488 | Stat5a | 2 | 0.967240 | -0.82 | 4.8e-02 | Click! |
chr11_100883192_100883343 | Stat5a | 4248 | 0.157314 | -0.77 | 7.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_81366011_81366177 | 38.62 |
Gm49555 |
predicted gene, 49555 |
75932 |
0.11 |
chr9_74892080_74892501 | 35.98 |
Onecut1 |
one cut domain, family member 1 |
25806 |
0.14 |
chr1_44576732_44576903 | 34.78 |
Gm37626 |
predicted gene, 37626 |
15932 |
0.19 |
chr11_111269853_111270023 | 31.36 |
Gm11675 |
predicted gene 11675 |
6162 |
0.34 |
chr16_87636019_87636210 | 31.31 |
Gm22808 |
predicted gene, 22808 |
14994 |
0.19 |
chr16_48765285_48765461 | 29.95 |
Trat1 |
T cell receptor associated transmembrane adaptor 1 |
6583 |
0.2 |
chr14_103463834_103464050 | 29.25 |
Gm34907 |
predicted gene, 34907 |
23 |
0.98 |
chr17_63010946_63011130 | 28.35 |
Gm25348 |
predicted gene, 25348 |
85962 |
0.1 |
chr7_35748679_35748830 | 27.90 |
Dpy19l3 |
dpy-19-like 3 (C. elegans) |
5601 |
0.2 |
chr9_46116938_46117103 | 26.81 |
Sik3 |
SIK family kinase 3 |
6110 |
0.2 |
chr1_186325767_186325937 | 26.60 |
Gm37491 |
predicted gene, 37491 |
21463 |
0.24 |
chr18_7657901_7658087 | 26.28 |
Mpp7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
31128 |
0.17 |
chr2_42022610_42022815 | 26.02 |
Gm13461 |
predicted gene 13461 |
33883 |
0.23 |
chr2_112595326_112595515 | 25.71 |
Gm44374 |
predicted gene, 44374 |
18610 |
0.17 |
chr17_46439501_46439689 | 25.36 |
Gm5093 |
predicted gene 5093 |
502 |
0.57 |
chr13_4577869_4578048 | 24.86 |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
801 |
0.61 |
chr12_103991999_103992602 | 23.89 |
Serpina11 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
2343 |
0.16 |
chr6_84544470_84544631 | 23.79 |
4930504D19Rik |
RIKEN cDNA 4930504D19 gene |
8674 |
0.25 |
chr2_110226601_110226752 | 23.68 |
Gm22997 |
predicted gene, 22997 |
8673 |
0.19 |
chr13_46051322_46051732 | 23.27 |
Gm45949 |
predicted gene, 45949 |
9070 |
0.25 |
chr4_54733562_54733749 | 23.05 |
Gm12477 |
predicted gene 12477 |
63463 |
0.11 |
chr11_116206084_116206272 | 22.65 |
Ten1 |
TEN1 telomerase capping complex subunit |
4756 |
0.1 |
chr6_149189382_149189536 | 22.51 |
Amn1 |
antagonist of mitotic exit network 1 |
747 |
0.6 |
chr19_29968799_29968964 | 22.48 |
Il33 |
interleukin 33 |
17065 |
0.16 |
chr9_67824580_67824733 | 21.92 |
C2cd4a |
C2 calcium-dependent domain containing 4A |
7674 |
0.18 |
chr4_103933550_103933744 | 21.73 |
Gm12719 |
predicted gene 12719 |
5894 |
0.25 |
chr13_62909790_62909949 | 21.67 |
Fbp1 |
fructose bisphosphatase 1 |
21587 |
0.13 |
chr7_121802332_121802546 | 21.50 |
Gm44740 |
predicted gene 44740 |
36626 |
0.13 |
chr6_143857220_143857571 | 21.50 |
Sox5 |
SRY (sex determining region Y)-box 5 |
89693 |
0.09 |
chr12_3537548_3537727 | 21.49 |
Rps7-ps2 |
ribosomal protein S7, pseudogene 2 |
14369 |
0.17 |
chr1_73036643_73036816 | 21.43 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
12160 |
0.22 |
chr13_42044377_42044528 | 20.87 |
Gm28707 |
predicted gene 28707 |
4882 |
0.24 |
chr11_11946176_11946345 | 20.69 |
Grb10 |
growth factor receptor bound protein 10 |
70 |
0.98 |
chr10_95144816_95145075 | 20.60 |
Gm29684 |
predicted gene, 29684 |
880 |
0.54 |
chr1_10156105_10156276 | 20.13 |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
1660 |
0.36 |
chr11_101342858_101343022 | 20.08 |
Gm28156 |
predicted gene 28156 |
4999 |
0.06 |
chr3_107238675_107238837 | 20.07 |
Prok1 |
prokineticin 1 |
104 |
0.95 |
chr13_31511172_31511336 | 20.04 |
Foxq1 |
forkhead box Q1 |
44880 |
0.1 |
chr1_193928644_193928965 | 19.94 |
Gm21362 |
predicted gene, 21362 |
61795 |
0.15 |
chr9_74791375_74791538 | 19.87 |
Gm22315 |
predicted gene, 22315 |
9386 |
0.19 |
chr1_127899545_127899941 | 19.72 |
Rab3gap1 |
RAB3 GTPase activating protein subunit 1 |
1170 |
0.47 |
chr1_191591538_191591710 | 19.58 |
Gm37349 |
predicted gene, 37349 |
6023 |
0.16 |
chr18_57935552_57935711 | 19.32 |
Slc12a2 |
solute carrier family 12, member 2 |
8426 |
0.28 |
chr10_95424636_95424797 | 18.91 |
5730420D15Rik |
RIKEN cDNA 5730420D15 gene |
7341 |
0.13 |
chr8_9501766_9501947 | 18.75 |
4930435N07Rik |
RIKEN cDNA 4930435N07 gene |
42764 |
0.13 |
chr4_123026987_123027301 | 18.56 |
Trit1 |
tRNA isopentenyltransferase 1 |
10547 |
0.14 |
chrX_156479377_156479543 | 18.22 |
Gm23404 |
predicted gene, 23404 |
23365 |
0.24 |
chr3_145775927_145776137 | 18.12 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
15284 |
0.2 |
chr12_69419094_69419426 | 17.96 |
Gm9887 |
predicted gene 9887 |
46792 |
0.08 |
chr10_4729593_4729756 | 17.91 |
Esr1 |
estrogen receptor 1 (alpha) |
17023 |
0.27 |
chr8_66494561_66494830 | 17.42 |
Gm32568 |
predicted gene, 32568 |
364 |
0.85 |
chr5_151060423_151060640 | 17.37 |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
28731 |
0.19 |
chr13_44445691_44446120 | 17.14 |
Gm27036 |
predicted gene, 27036 |
6092 |
0.16 |
chr9_106273556_106273707 | 17.11 |
Poc1a |
POC1 centriolar protein A |
7430 |
0.12 |
chr11_16589151_16589356 | 17.09 |
Gm12663 |
predicted gene 12663 |
46813 |
0.12 |
chr16_41161594_41161767 | 17.08 |
Gm26381 |
predicted gene, 26381 |
56065 |
0.15 |
chr9_107308727_107308886 | 17.05 |
Gm17041 |
predicted gene 17041 |
6968 |
0.1 |
chr9_74947099_74947265 | 16.89 |
Fam214a |
family with sequence similarity 214, member A |
5702 |
0.22 |
chr3_127341537_127341688 | 16.68 |
Gm42970 |
predicted gene 42970 |
41939 |
0.1 |
chr3_152762447_152762598 | 16.62 |
Pigk |
phosphatidylinositol glycan anchor biosynthesis, class K |
859 |
0.63 |
chr9_74304589_74304740 | 16.56 |
Wdr72 |
WD repeat domain 72 |
30530 |
0.19 |
chr8_10962092_10962324 | 16.53 |
Gm44956 |
predicted gene 44956 |
8606 |
0.11 |
chr3_156794416_156794567 | 16.42 |
Gm15578 |
predicted gene 15578 |
21546 |
0.19 |
chr11_101282399_101282564 | 16.41 |
Coa3 |
cytochrome C oxidase assembly factor 3 |
3367 |
0.08 |
chr1_50806813_50807031 | 16.30 |
Gm28321 |
predicted gene 28321 |
8453 |
0.28 |
chr2_8124301_8124468 | 16.29 |
Gm13254 |
predicted gene 13254 |
23481 |
0.29 |
chr11_11945884_11946107 | 16.13 |
Grb10 |
growth factor receptor bound protein 10 |
335 |
0.89 |
chr14_62198583_62198734 | 16.05 |
Gm26969 |
predicted gene, 26969 |
5694 |
0.23 |
chr7_88307523_88307674 | 15.99 |
Gm44751 |
predicted gene 44751 |
3880 |
0.23 |
chr8_117667774_117667955 | 15.89 |
Sdr42e1 |
short chain dehydrogenase/reductase family 42E, member 1 |
3683 |
0.18 |
chr11_4378478_4378660 | 15.87 |
Hormad2 |
HORMA domain containing 2 |
48693 |
0.1 |
chr8_33950546_33950701 | 15.76 |
Rbpms |
RNA binding protein gene with multiple splicing |
20760 |
0.14 |
chr6_43850496_43850673 | 15.54 |
Gm7783 |
predicted gene 7783 |
6320 |
0.26 |
chr8_44373378_44373540 | 15.48 |
Gm37972 |
predicted gene, 37972 |
144914 |
0.04 |
chr9_121881807_121881992 | 15.25 |
Gm47113 |
predicted gene, 47113 |
12403 |
0.08 |
chr2_107628721_107628872 | 15.14 |
Gm9864 |
predicted gene 9864 |
28257 |
0.26 |
chr9_61312955_61313113 | 15.07 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
19225 |
0.19 |
chr13_101718863_101719071 | 14.92 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
16863 |
0.2 |
chr9_50492228_50492379 | 14.70 |
Plet1 |
placenta expressed transcript 1 |
2222 |
0.22 |
chr16_49775651_49775805 | 14.65 |
Gm15518 |
predicted gene 15518 |
23142 |
0.2 |
chr14_10750731_10751121 | 14.46 |
Fhitos |
fragile histidine triad gene, opposite strand |
12373 |
0.25 |
chr7_123643560_123643752 | 14.37 |
Zkscan2 |
zinc finger with KRAB and SCAN domains 2 |
143207 |
0.04 |
chr9_74672657_74672818 | 14.32 |
Gm27233 |
predicted gene 27233 |
36525 |
0.18 |
chrX_111626357_111626522 | 14.30 |
Gm7340 |
predicted gene 7340 |
54740 |
0.14 |
chr8_128648206_128648359 | 14.24 |
Gm26002 |
predicted gene, 26002 |
2715 |
0.24 |
chr3_67558553_67558734 | 14.16 |
Gm35299 |
predicted gene, 35299 |
5218 |
0.14 |
chr18_36656472_36656632 | 14.15 |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
1042 |
0.31 |
chr13_37790260_37790434 | 14.10 |
Gm46411 |
predicted gene, 46411 |
9443 |
0.15 |
chrX_165189117_165189280 | 13.99 |
Glra2 |
glycine receptor, alpha 2 subunit |
138195 |
0.05 |
chr7_44298836_44299206 | 13.96 |
Gm7238 |
predicted gene 7238 |
1866 |
0.11 |
chr12_104346326_104346873 | 13.93 |
Serpina3k |
serine (or cysteine) peptidase inhibitor, clade A, member 3K |
8113 |
0.12 |
chr8_23182827_23182999 | 13.91 |
Gpat4 |
glycerol-3-phosphate acyltransferase 4 |
2476 |
0.17 |
chr14_116442003_116442157 | 13.82 |
Gm38045 |
predicted gene, 38045 |
308135 |
0.01 |
chr9_122634913_122635137 | 13.79 |
Gm47134 |
predicted gene, 47134 |
12805 |
0.13 |
chr9_74888553_74888706 | 13.75 |
Onecut1 |
one cut domain, family member 1 |
22145 |
0.14 |
chr18_81319673_81319824 | 13.69 |
Gm30192 |
predicted gene, 30192 |
55040 |
0.14 |
chr12_57537784_57538085 | 13.62 |
Foxa1 |
forkhead box A1 |
8187 |
0.15 |
chr1_58071873_58072151 | 13.59 |
Aox3 |
aldehyde oxidase 3 |
41118 |
0.12 |
chr4_100041906_100042269 | 13.57 |
Gm12702 |
predicted gene 12702 |
10433 |
0.22 |
chr7_26313878_26314034 | 13.56 |
Gm42375 |
predicted gene, 42375 |
6670 |
0.14 |
chr13_46153447_46153609 | 13.53 |
Gm10113 |
predicted gene 10113 |
37518 |
0.19 |
chr12_103996630_103996801 | 13.23 |
Gm28577 |
predicted gene 28577 |
136 |
0.92 |
chr13_63665698_63665976 | 13.18 |
Gm47387 |
predicted gene, 47387 |
4040 |
0.18 |
chr6_38769722_38769895 | 13.11 |
Hipk2 |
homeodomain interacting protein kinase 2 |
26548 |
0.2 |
chr15_59195501_59195712 | 13.08 |
Rpl7-ps8 |
ribosomal protein L7, pseudogene 8 |
15302 |
0.19 |
chr2_134708873_134709037 | 13.05 |
Gm14037 |
predicted gene 14037 |
22152 |
0.2 |
chr8_76148232_76148470 | 13.03 |
Gm45742 |
predicted gene 45742 |
31324 |
0.21 |
chr8_27259396_27259635 | 12.97 |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
814 |
0.47 |
chr7_140719940_140720091 | 12.92 |
Olfr542-ps1 |
olfactory receptor 542, pseudogene 1 |
1267 |
0.28 |
chr8_46918583_46918754 | 12.70 |
1700011L03Rik |
RIKEN cDNA 1700011L03 gene |
30131 |
0.16 |
chr3_58454505_58454707 | 12.66 |
Tsc22d2 |
TSC22 domain family, member 2 |
37122 |
0.13 |
chr6_99301984_99302270 | 12.61 |
Foxp1 |
forkhead box P1 |
35595 |
0.2 |
chr14_117750473_117750636 | 12.54 |
Mir6239 |
microRNA 6239 |
203293 |
0.03 |
chr5_20319781_20319982 | 12.48 |
Gm22755 |
predicted gene, 22755 |
55540 |
0.13 |
chr2_72206740_72207276 | 12.42 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
8209 |
0.18 |
chr1_55685863_55686014 | 12.41 |
Plcl1 |
phospholipase C-like 1 |
16087 |
0.27 |
chr15_9602541_9602716 | 12.37 |
Il7r |
interleukin 7 receptor |
72452 |
0.11 |
chr1_40236870_40237279 | 12.35 |
Gm38070 |
predicted gene, 38070 |
946 |
0.59 |
chr10_68137101_68137496 | 12.33 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
672 |
0.78 |
chr3_144114277_144114432 | 12.32 |
Gm34078 |
predicted gene, 34078 |
21400 |
0.21 |
chr9_114857411_114857562 | 12.26 |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
13330 |
0.16 |
chr17_43282615_43282766 | 12.09 |
Adgrf1 |
adhesion G protein-coupled receptor F1 |
12361 |
0.26 |
chr3_76637152_76637321 | 12.06 |
Fstl5 |
follistatin-like 5 |
43686 |
0.19 |
chr7_144928968_144929143 | 12.04 |
Ccnd1 |
cyclin D1 |
9142 |
0.12 |
chr4_65080374_65080537 | 12.04 |
Pappa |
pregnancy-associated plasma protein A |
43719 |
0.19 |
chr18_55182860_55183019 | 12.01 |
Gm22597 |
predicted gene, 22597 |
3099 |
0.29 |
chr10_87933208_87933374 | 12.00 |
Tyms-ps |
thymidylate synthase, pseudogene |
33556 |
0.14 |
chr8_123811498_123811717 | 11.90 |
Rab4a |
RAB4A, member RAS oncogene family |
5539 |
0.1 |
chr8_36753814_36753974 | 11.89 |
Dlc1 |
deleted in liver cancer 1 |
20840 |
0.26 |
chr8_54468376_54468527 | 11.86 |
Gm45553 |
predicted gene 45553 |
45699 |
0.14 |
chr19_40190790_40190960 | 11.85 |
Gm5827 |
predicted gene 5827 |
163 |
0.94 |
chr6_101160855_101161061 | 11.80 |
Gm19726 |
predicted gene, 19726 |
14479 |
0.15 |
chr17_50990916_50991076 | 11.73 |
Tbc1d5 |
TBC1 domain family, member 5 |
6370 |
0.3 |
chr1_162986828_162987029 | 11.73 |
Fmo3 |
flavin containing monooxygenase 3 |
2400 |
0.25 |
chr1_100497686_100497861 | 11.73 |
Gm18700 |
predicted gene, 18700 |
99302 |
0.08 |
chr15_41724355_41724527 | 11.63 |
Oxr1 |
oxidation resistance 1 |
13837 |
0.26 |
chr10_95264989_95265220 | 11.50 |
Gm48880 |
predicted gene, 48880 |
49749 |
0.1 |
chrX_42602450_42602620 | 11.45 |
Sh2d1a |
SH2 domain containing 1A |
75950 |
0.1 |
chr9_122713984_122714139 | 11.39 |
Gm47136 |
predicted gene, 47136 |
272 |
0.8 |
chr2_73628966_73629117 | 11.37 |
Chn1 |
chimerin 1 |
3301 |
0.21 |
chr10_95144611_95144805 | 11.34 |
Gm29684 |
predicted gene, 29684 |
1117 |
0.44 |
chr1_160968204_160968356 | 11.32 |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
10305 |
0.07 |
chr15_87233349_87233529 | 11.31 |
A930027H12Rik |
RIKEN cDNA A930027H12 gene |
10111 |
0.25 |
chr10_87902038_87902205 | 11.28 |
Igf1os |
insulin-like growth factor 1, opposite strand |
38740 |
0.13 |
chr19_40164076_40164449 | 11.27 |
Cyp2c70 |
cytochrome P450, family 2, subfamily c, polypeptide 70 |
23024 |
0.14 |
chr2_11402649_11402823 | 11.25 |
8030442B05Rik |
RIKEN cDNA 8030442B05 gene |
4235 |
0.12 |
chr19_32992433_32992599 | 11.21 |
Gm36860 |
predicted gene, 36860 |
12453 |
0.25 |
chr5_151018980_151019139 | 11.10 |
Gm8675 |
predicted gene 8675 |
9758 |
0.23 |
chr12_3647979_3648147 | 11.10 |
Dtnb |
dystrobrevin, beta |
15141 |
0.21 |
chr2_8123996_8124147 | 11.07 |
Gm13254 |
predicted gene 13254 |
23794 |
0.29 |
chr1_157187310_157187489 | 11.03 |
Rasal2 |
RAS protein activator like 2 |
5958 |
0.24 |
chr5_89352355_89352713 | 10.97 |
Gc |
vitamin D binding protein |
83094 |
0.1 |
chr16_43408501_43408652 | 10.96 |
Gm15713 |
predicted gene 15713 |
11620 |
0.2 |
chr18_64999443_64999608 | 10.93 |
Gm50368 |
predicted gene, 50368 |
1650 |
0.42 |
chr18_81321681_81321954 | 10.89 |
Gm30192 |
predicted gene, 30192 |
57109 |
0.13 |
chr1_163150756_163150961 | 10.88 |
Gm22434 |
predicted gene, 22434 |
32631 |
0.15 |
chr17_84320524_84320687 | 10.70 |
Thada |
thyroid adenoma associated |
6926 |
0.21 |
chr18_29774726_29774892 | 10.70 |
Gm7917 |
predicted gene 7917 |
117213 |
0.07 |
chr10_95254536_95254702 | 10.68 |
Gm48880 |
predicted gene, 48880 |
60234 |
0.08 |
chr19_20612745_20612960 | 10.67 |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
10891 |
0.21 |
chr18_29774940_29775095 | 10.60 |
Gm7917 |
predicted gene 7917 |
117421 |
0.07 |
chr5_34528669_34529011 | 10.54 |
Gm22847 |
predicted gene, 22847 |
1809 |
0.2 |
chr1_186325513_186325749 | 10.53 |
Gm37491 |
predicted gene, 37491 |
21684 |
0.24 |
chr10_66912996_66913163 | 10.52 |
1110002J07Rik |
RIKEN cDNA 1110002J07 gene |
4660 |
0.18 |
chr5_105354145_105354308 | 10.51 |
Gbp11 |
guanylate binding protein 11 |
7754 |
0.17 |
chr1_55092544_55092728 | 10.48 |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
4322 |
0.12 |
chr3_135146834_135146985 | 10.45 |
Gm24048 |
predicted gene, 24048 |
499 |
0.77 |
chr9_69334819_69334993 | 10.24 |
Gm15511 |
predicted gene 15511 |
29341 |
0.16 |
chr6_149222350_149222503 | 10.22 |
1700003I16Rik |
RIKEN cDNA 1700003I16 gene |
7241 |
0.17 |
chr14_63326787_63326957 | 10.22 |
Gm5463 |
predicted gene 5463 |
2348 |
0.25 |
chr6_94083257_94083610 | 10.16 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
169743 |
0.03 |
chr13_60724404_60724555 | 10.14 |
Dapk1 |
death associated protein kinase 1 |
28066 |
0.14 |
chr11_16832225_16832426 | 10.14 |
Egfros |
epidermal growth factor receptor, opposite strand |
1623 |
0.42 |
chr4_47366562_47366857 | 10.09 |
Tgfbr1 |
transforming growth factor, beta receptor I |
13099 |
0.22 |
chr12_51259911_51260071 | 10.07 |
Rps11-ps4 |
ribosomal protein S11, pseudogene 4 |
37496 |
0.18 |
chr13_31178510_31178680 | 10.06 |
Gm11372 |
predicted gene 11372 |
20491 |
0.2 |
chr2_131869043_131869244 | 10.06 |
Erv3 |
endogenous retroviral sequence 3 |
9396 |
0.12 |
chr13_58962693_58962856 | 10.04 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
91039 |
0.06 |
chr17_45880763_45881199 | 10.00 |
4930542M03Rik |
RIKEN cDNA 4930542M03 gene |
471 |
0.78 |
chr10_17522048_17522257 | 9.97 |
Gm47769 |
predicted gene, 47769 |
1544 |
0.38 |
chr4_134899949_134900100 | 9.97 |
Tmem50a |
transmembrane protein 50A |
14991 |
0.14 |
chr12_77056757_77057146 | 9.95 |
Gm35189 |
predicted gene, 35189 |
14750 |
0.21 |
chr7_72323573_72323742 | 9.93 |
Mctp2 |
multiple C2 domains, transmembrane 2 |
17049 |
0.28 |
chr3_149437041_149437628 | 9.92 |
Gm30382 |
predicted gene, 30382 |
7942 |
0.29 |
chr2_153427016_153427191 | 9.92 |
Gm14472 |
predicted gene 14472 |
13254 |
0.15 |
chr19_21624893_21625081 | 9.89 |
1110059E24Rik |
RIKEN cDNA 1110059E24 gene |
5781 |
0.23 |
chr4_130129683_130130093 | 9.89 |
Hcrtr1 |
hypocretin (orexin) receptor 1 |
7740 |
0.15 |
chr4_10854377_10854556 | 9.89 |
Gm12919 |
predicted gene 12919 |
623 |
0.61 |
chr1_16271768_16272085 | 9.86 |
Gm7568 |
predicted gene 7568 |
18297 |
0.19 |
chr2_58562897_58563104 | 9.84 |
Acvr1 |
activin A receptor, type 1 |
3826 |
0.25 |
chr10_4605740_4606032 | 9.82 |
Esr1 |
estrogen receptor 1 (alpha) |
5707 |
0.24 |
chr7_4815487_4815639 | 9.81 |
Ube2s |
ubiquitin-conjugating enzyme E2S |
2973 |
0.11 |
chr8_80289362_80289553 | 9.78 |
Gm45430 |
predicted gene 45430 |
94258 |
0.08 |
chr2_145830529_145830695 | 9.77 |
Rin2 |
Ras and Rab interactor 2 |
8323 |
0.21 |
chr9_108378988_108379161 | 9.74 |
Usp4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
2297 |
0.12 |
chr6_24210867_24211018 | 9.72 |
Slc13a1 |
solute carrier family 13 (sodium/sulfate symporters), member 1 |
42850 |
0.16 |
chr9_14045065_14045224 | 9.70 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
44476 |
0.14 |
chr12_104074072_104074238 | 9.66 |
Serpina4-ps1 |
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1 |
6494 |
0.11 |
chr9_74228469_74228620 | 9.61 |
Wdr72 |
WD repeat domain 72 |
45590 |
0.18 |
chr16_23326583_23326734 | 9.58 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
36188 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 40.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
7.3 | 36.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
5.6 | 22.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.0 | 15.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
5.0 | 15.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
4.3 | 12.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
4.1 | 12.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.0 | 23.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
3.5 | 10.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
3.4 | 10.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
3.4 | 13.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.2 | 9.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.9 | 8.8 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.9 | 11.6 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.9 | 8.7 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
2.9 | 11.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
2.8 | 8.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.7 | 8.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
2.6 | 7.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.5 | 4.9 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
2.4 | 7.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.3 | 7.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
2.3 | 11.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.1 | 6.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.1 | 6.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
2.0 | 8.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.0 | 7.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.9 | 3.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.9 | 9.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.9 | 5.7 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.9 | 5.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.9 | 5.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.8 | 5.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.8 | 18.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.8 | 5.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.7 | 5.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.7 | 5.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.7 | 5.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.7 | 6.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.6 | 8.1 | GO:0006971 | hypotonic response(GO:0006971) |
1.6 | 4.8 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.6 | 9.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.6 | 12.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.6 | 3.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.6 | 4.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.6 | 3.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.5 | 3.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.5 | 3.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.5 | 9.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.5 | 4.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.5 | 4.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.5 | 4.4 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.5 | 4.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.5 | 4.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.5 | 5.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.4 | 8.7 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.4 | 4.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.4 | 4.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.4 | 4.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.4 | 9.6 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 2.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.3 | 4.0 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.3 | 2.6 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 7.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.3 | 6.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.3 | 11.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.3 | 2.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.3 | 5.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.3 | 7.6 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
1.3 | 10.1 | GO:0007343 | egg activation(GO:0007343) |
1.3 | 2.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.3 | 3.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.2 | 3.7 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.2 | 4.9 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.2 | 3.7 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
1.2 | 6.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.2 | 3.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.2 | 4.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.2 | 6.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.2 | 4.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.2 | 34.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.2 | 2.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.2 | 3.5 | GO:0031296 | B cell costimulation(GO:0031296) |
1.1 | 8.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 3.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 6.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.1 | 11.3 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.1 | 2.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.1 | 3.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.1 | 6.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.1 | 4.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 3.2 | GO:0070268 | cornification(GO:0070268) |
1.1 | 2.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.0 | 3.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
1.0 | 2.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.0 | 11.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.0 | 5.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.0 | 2.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
1.0 | 10.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.0 | 4.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 2.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 2.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.0 | 3.9 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
1.0 | 10.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.0 | 1.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.9 | 3.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.9 | 0.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.9 | 4.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.9 | 2.8 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.9 | 4.7 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.9 | 1.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.9 | 3.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.9 | 4.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.9 | 1.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.9 | 1.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.9 | 3.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.9 | 2.6 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.9 | 2.6 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.9 | 2.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.9 | 1.7 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.9 | 2.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.8 | 4.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 4.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 2.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.8 | 4.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.8 | 18.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.8 | 3.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.8 | 3.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.8 | 0.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.8 | 2.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.8 | 3.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.8 | 3.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.8 | 1.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.8 | 3.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 4.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.8 | 2.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.8 | 3.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 1.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 3.9 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.8 | 6.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.8 | 2.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.8 | 1.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.8 | 7.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.8 | 7.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.8 | 3.0 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.7 | 2.2 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 3.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.7 | 1.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.7 | 4.5 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.7 | 9.6 | GO:0045056 | transcytosis(GO:0045056) |
0.7 | 2.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 6.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.7 | 2.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.7 | 1.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 5.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.7 | 2.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 3.5 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.7 | 2.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 0.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.7 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 4.2 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 2.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.7 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.7 | 4.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.7 | 1.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.7 | 3.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 0.7 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.7 | 2.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.7 | 2.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 2.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 2.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 0.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.7 | 1.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.7 | 0.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 2.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.7 | 16.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.7 | 3.3 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.7 | 0.7 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.6 | 1.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.6 | 2.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.6 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.6 | 1.9 | GO:0061724 | lipophagy(GO:0061724) |
0.6 | 1.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.6 | 5.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 1.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 0.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 1.9 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 1.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 5.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.6 | 0.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.6 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 3.8 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.6 | 23.3 | GO:0048536 | spleen development(GO:0048536) |
0.6 | 2.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 8.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.6 | 3.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 1.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 12.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.6 | 1.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 3.1 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.6 | 0.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 2.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 2.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 3.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 1.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 1.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 6.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.6 | 0.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 4.8 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.6 | 6.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 1.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.6 | 13.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.6 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 1.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.6 | 0.6 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.6 | 2.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 1.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 2.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 1.2 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.6 | 1.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.6 | 1.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.6 | 2.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 0.6 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.6 | 0.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.6 | 3.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 12.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 1.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 1.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.6 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 2.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.6 | 2.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.6 | 5.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 2.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 2.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 1.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.6 | 7.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.6 | 8.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 2.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 2.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.6 | 1.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 2.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 2.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 1.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 1.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 1.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 1.6 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.5 | 0.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 3.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.5 | 1.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.5 | 1.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.5 | 1.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.5 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 1.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.5 | 1.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.5 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 2.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 1.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 3.1 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 2.6 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 4.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.5 | 2.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.5 | 0.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.5 | 1.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 20.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.5 | 1.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 6.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 1.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 1.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 3.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 0.5 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.5 | 1.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 2.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 2.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 1.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 6.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 2.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 1.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 1.5 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 0.5 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 6.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 0.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.5 | 2.0 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.5 | 0.5 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.5 | 2.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.5 | 2.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 1.0 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.5 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 3.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.5 | 0.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 1.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.5 | 0.9 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.5 | 4.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.5 | 4.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 6.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.5 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 1.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.9 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 5.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 2.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.5 | 2.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.5 | 0.9 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 4.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.5 | 1.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.5 | 3.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 0.5 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.4 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 4.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 1.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 0.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 1.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 1.8 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 0.4 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.4 | 7.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.4 | 1.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 2.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 0.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 1.3 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 0.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 3.4 | GO:0015824 | proline transport(GO:0015824) |
0.4 | 0.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 4.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 0.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 0.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.4 | 2.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.8 | GO:0006901 | vesicle coating(GO:0006901) |
0.4 | 1.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 1.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.4 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.4 | 1.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 0.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 1.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 1.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.4 | 0.8 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.4 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 1.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 0.8 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.4 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 6.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.4 | 3.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.4 | 1.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 0.4 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.4 | 2.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 3.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 2.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.4 | 4.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 1.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 4.4 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 2.2 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.4 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 0.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.4 | 0.7 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 1.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 5.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 1.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 0.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 1.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 6.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 2.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 2.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 1.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 2.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 1.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 0.7 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.4 | 1.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.3 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.3 | 2.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 2.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.7 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.3 | 1.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.0 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.3 | 2.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 12.6 | GO:0007584 | response to nutrient(GO:0007584) |
0.3 | 1.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 1.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 2.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 1.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.3 | 0.3 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 2.7 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 2.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 1.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 2.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.3 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 0.6 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.3 | 0.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 1.3 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.3 | 0.6 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 2.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 4.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 0.9 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 2.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 0.9 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.3 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.6 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.3 | 0.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 2.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 1.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 1.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 3.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 0.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.6 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.3 | 4.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.3 | 0.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 0.9 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.3 | 1.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.6 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.3 | 0.6 | GO:0036166 | phenotypic switching(GO:0036166) |
0.3 | 1.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 3.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 2.4 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.3 | 1.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 2.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 4.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 2.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 1.2 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 1.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 2.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 1.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 1.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 1.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 0.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 1.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.4 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 1.1 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.3 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 6.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 2.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.8 | GO:0046959 | habituation(GO:0046959) |
0.3 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 4.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.8 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 0.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 0.8 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.3 | 0.8 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 8.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 1.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 1.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 0.3 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 1.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 2.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 2.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 0.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.9 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 1.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 4.0 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.3 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.3 | GO:1901374 | acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) acetate ester transport(GO:1901374) |
0.3 | 2.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 1.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 0.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 0.8 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 21.9 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.3 | 2.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.3 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 0.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 6.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 0.5 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.3 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 0.8 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.3 | 0.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.3 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.3 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.3 | 0.3 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 0.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.3 | 2.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 3.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 0.5 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.3 | 0.5 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 0.3 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.3 | 4.6 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.3 | 0.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 1.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.2 | 0.5 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 2.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.7 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 3.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.7 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 2.9 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.2 | 1.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 1.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 1.9 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.2 | 2.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.2 | 1.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.7 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.9 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 0.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.7 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 1.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.7 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.2 | 0.5 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.2 | 2.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 2.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.2 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.2 | 1.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.7 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 2.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.7 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.2 | 1.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.4 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.2 | 0.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 9.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 1.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 1.8 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.2 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 1.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 1.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.2 | 0.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 2.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.2 | 1.9 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.2 | 15.7 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.2 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 1.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 1.9 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.6 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.2 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 1.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.4 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 2.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.4 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.2 | 9.4 | GO:1901292 | nucleoside phosphate catabolic process(GO:1901292) |
0.2 | 4.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 1.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 2.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 1.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 4.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 1.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.2 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.2 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 3.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 1.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 2.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.8 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 3.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 2.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 1.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 1.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 1.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 3.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 6.6 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 3.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 1.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 2.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.2 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.2 | 2.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 2.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.2 | 0.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 1.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.9 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 0.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.2 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 0.9 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 0.4 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 3.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 4.4 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 0.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 2.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 2.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 0.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 2.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.9 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 0.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 1.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 2.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 1.7 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.2 | 1.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.5 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.2 | 1.3 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.7 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 1.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.2 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 1.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.3 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.2 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 1.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 1.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 1.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.3 | GO:2000399 | positive regulation of thymocyte apoptotic process(GO:0070245) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.7 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.2 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.2 | 1.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 1.8 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.2 | 3.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 5.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 1.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 1.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 2.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 1.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.9 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 0.1 | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 3.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 2.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.7 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.4 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 1.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 3.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 2.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 1.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 4.2 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.3 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.1 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 2.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 2.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 1.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.7 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 1.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.8 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 1.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.1 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.9 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.6 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 2.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.2 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 1.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.9 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.2 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.1 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.3 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.1 | 0.5 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.5 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.1 | 0.7 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.8 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.3 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 1.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 2.4 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 1.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.3 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 1.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.8 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 3.4 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.4 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 6.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.7 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 0.7 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.2 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.5 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.2 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.2 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 2.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 1.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 2.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.7 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.1 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.1 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.1 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 0.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 1.0 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.1 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 1.7 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 0.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.1 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.1 | GO:1905209 | positive regulation of cardiocyte differentiation(GO:1905209) positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 3.4 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.6 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.1 | 5.0 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.0 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.3 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.0 | 0.1 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.4 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.0 | 0.0 | GO:0009215 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.2 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0032634 | interleukin-5 production(GO:0032634) |
0.0 | 0.1 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.0 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.0 | 0.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 3.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.0 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.4 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 24.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.0 | 0.0 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.1 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.0 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.0 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.0 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.0 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 40.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.6 | 18.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.1 | 12.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
3.0 | 12.1 | GO:0070545 | PeBoW complex(GO:0070545) |
2.6 | 7.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.5 | 9.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.3 | 9.2 | GO:0005955 | calcineurin complex(GO:0005955) |
2.3 | 6.9 | GO:0048179 | activin receptor complex(GO:0048179) |
2.1 | 6.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.9 | 9.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.8 | 5.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.5 | 12.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.4 | 8.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.4 | 6.8 | GO:0097433 | dense body(GO:0097433) |
1.4 | 5.4 | GO:0071203 | WASH complex(GO:0071203) |
1.3 | 6.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.3 | 6.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.2 | 5.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 4.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.1 | 7.9 | GO:0045180 | basal cortex(GO:0045180) |
1.1 | 5.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 2.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 15.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.9 | 9.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.9 | 2.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 3.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.8 | 4.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.8 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.8 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 4.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.8 | 0.8 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 6.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.7 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 8.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.7 | 2.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 5.5 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 2.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.7 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.7 | 2.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.7 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.6 | 10.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 1.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 1.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 1.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.6 | 13.2 | GO:0000786 | nucleosome(GO:0000786) |
0.6 | 3.4 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 4.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 3.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 1.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 2.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 2.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 2.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 1.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 6.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 6.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 5.4 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 3.2 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 2.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 1.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 1.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 15.0 | GO:0031672 | A band(GO:0031672) |
0.4 | 0.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 6.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 2.9 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 5.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.4 | 4.5 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 1.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 3.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.4 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 3.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 4.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.4 | 3.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 0.4 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.4 | 2.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.4 | 1.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 1.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 4.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 5.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 11.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 1.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 0.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 6.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 5.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 15.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 3.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 4.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 19.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 9.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.3 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 12.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 1.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 0.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 4.9 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 2.1 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 1.8 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 1.5 | GO:0002177 | manchette(GO:0002177) |
0.3 | 3.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 4.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 1.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 1.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 2.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 2.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 0.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 6.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 3.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 2.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 5.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 2.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 2.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 2.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 12.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 3.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 6.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 8.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.4 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 6.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 1.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.9 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 14.3 | GO:0005814 | centriole(GO:0005814) |
0.2 | 4.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 3.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 1.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 3.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.6 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 3.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 2.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 25.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 2.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 3.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 8.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 3.2 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 7.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 10.6 | GO:0005901 | caveola(GO:0005901) |
0.2 | 4.1 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 22.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.4 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.2 | 1.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 5.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 4.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 7.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 2.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 5.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 4.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 3.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 13.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 1.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 3.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 5.8 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 3.1 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 20.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 19.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 2.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 148.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 2.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 25.0 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 9.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.8 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 2.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 5.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 2.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 2.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 2.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.6 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 6.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 1.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 5.3 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 4.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 1.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.4 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 3.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 1.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 1.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 2.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 2.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 3.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 1.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.4 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 33.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 56.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.9 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.0 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.0 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 14.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.3 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 47.8 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 33.3 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.2 | 42.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
6.0 | 17.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
5.5 | 22.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
4.0 | 16.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
4.0 | 8.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.4 | 13.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
3.4 | 30.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.3 | 9.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
3.2 | 9.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.2 | 9.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.8 | 8.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.8 | 8.4 | GO:0070538 | oleic acid binding(GO:0070538) |
2.7 | 8.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.4 | 9.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.4 | 7.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.4 | 14.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.4 | 7.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.3 | 7.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.3 | 6.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.3 | 9.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.2 | 4.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
2.1 | 2.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
2.1 | 8.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.1 | 2.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.0 | 43.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.9 | 5.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.8 | 9.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.8 | 5.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.7 | 8.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.6 | 3.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.6 | 17.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.5 | 4.5 | GO:0032190 | acrosin binding(GO:0032190) |
1.5 | 4.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.5 | 4.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 2.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.4 | 5.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.4 | 6.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 6.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 3.9 | GO:0055100 | adiponectin binding(GO:0055100) |
1.3 | 5.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.3 | 3.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.2 | 4.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.2 | 3.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.2 | 3.5 | GO:0035939 | microsatellite binding(GO:0035939) |
1.1 | 22.8 | GO:0003785 | actin monomer binding(GO:0003785) |
1.1 | 3.4 | GO:0008142 | oxysterol binding(GO:0008142) |
1.1 | 3.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.1 | 4.4 | GO:0043559 | insulin binding(GO:0043559) |
1.1 | 1.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
1.0 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.0 | 9.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 4.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.0 | 3.1 | GO:0034862 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
1.0 | 4.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.0 | 1.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 3.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.0 | 25.2 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.0 | 2.9 | GO:0004802 | transketolase activity(GO:0004802) |
1.0 | 1.0 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.0 | 2.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.0 | 7.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.0 | 2.9 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.0 | 6.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.9 | 3.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.9 | 10.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 3.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.9 | 4.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.9 | 29.6 | GO:0018734 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.9 | 7.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 2.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 2.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.8 | 3.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 8.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 0.8 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.8 | 2.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.8 | 2.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 1.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.8 | 3.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.8 | 5.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.8 | 2.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 3.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 6.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 3.9 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 3.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.8 | 2.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.8 | 3.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.8 | 3.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 2.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 5.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 3.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 3.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.8 | 6.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 9.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 2.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 3.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 5.2 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 2.2 | GO:0018557 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.7 | 3.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 14.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.7 | 2.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.7 | 9.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.7 | 2.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 2.1 | GO:0032564 | dATP binding(GO:0032564) |
0.7 | 2.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 1.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 3.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 2.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 2.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 6.8 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.7 | 6.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 2.7 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.7 | 6.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 2.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.7 | 6.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.7 | 2.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.6 | 4.5 | GO:0036122 | BMP binding(GO:0036122) |
0.6 | 2.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 4.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 1.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 3.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 13.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 7.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 2.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 9.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.6 | 1.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 2.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 2.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 24.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.6 | 4.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 17.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.6 | 2.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 1.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 1.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 1.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.6 | 2.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 2.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.6 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 1.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 1.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 7.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 2.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 1.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 1.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 7.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 2.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 1.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 2.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 1.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 1.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 3.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 6.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 1.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 0.5 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 2.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 1.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 1.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 5.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 1.9 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 13.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 9.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.5 | 9.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 8.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 2.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 1.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.5 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 0.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 2.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 1.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.3 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 1.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 2.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 5.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 4.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 8.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 0.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 2.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 3.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 5.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 1.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.4 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 0.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.4 | 5.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 2.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 1.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 1.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.4 | 32.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.4 | 2.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 6.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 2.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.1 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 2.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 3.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 2.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 3.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 1.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 4.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 6.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 0.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 1.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 3.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 3.2 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 2.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 6.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 1.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 2.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 2.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 3.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 1.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 2.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 2.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 2.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 1.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 2.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 3.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 2.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.9 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 8.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 17.4 | GO:0042562 | hormone binding(GO:0042562) |
0.3 | 0.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 2.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 1.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.3 | GO:0015927 | trehalase activity(GO:0015927) |
0.3 | 3.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 1.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 1.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 3.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 5.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 0.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 1.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 2.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 2.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.8 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.3 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 3.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 21.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 2.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 2.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 2.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 2.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 2.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 4.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 2.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.7 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 2.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 2.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 2.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.7 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 26.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.2 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 4.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 8.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 3.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 2.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 7.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.9 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 1.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 1.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 2.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 6.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 7.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 2.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 5.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.2 | 1.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 4.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 2.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 4.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 2.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 27.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 2.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 2.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 7.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.6 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 2.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 2.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.2 | 1.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 30.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 2.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 0.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 4.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 2.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 3.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 5.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 2.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 2.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 2.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 2.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 2.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 9.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 2.4 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 3.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 2.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 3.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 4.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 2.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 3.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.2 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 5.9 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 0.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 6.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 4.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 10.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 2.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.6 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 4.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 8.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 2.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 3.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 1.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 4.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 2.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 4.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 5.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 4.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 2.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 2.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 4.4 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 0.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 5.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 17.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 4.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 1.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 36.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 3.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 4.5 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.8 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 2.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 19.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 2.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 11.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 3.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.0 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 10.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 2.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 62.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.9 | 49.2 | PID IGF1 PATHWAY | IGF1 pathway |
1.2 | 31.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.0 | 11.1 | PID ALK2 PATHWAY | ALK2 signaling events |
1.0 | 37.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 28.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 16.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 2.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 21.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 12.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 5.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 3.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 2.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.5 | 8.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 2.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 10.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 16.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 4.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 7.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 3.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 2.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 4.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 3.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 11.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 2.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 3.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 6.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 7.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 4.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 5.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 1.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 4.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 3.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 3.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 11.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 35.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
3.2 | 54.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.0 | 12.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.5 | 1.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.2 | 35.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 43.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.1 | 7.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 16.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 15.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.0 | 45.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.0 | 11.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 7.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 1.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 27.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.8 | 8.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 7.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 1.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.7 | 13.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 6.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 7.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 10.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 10.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 5.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 1.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.6 | 0.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.6 | 3.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 5.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 4.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.5 | 5.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 13.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.5 | 5.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 7.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 1.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.5 | 1.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 9.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 5.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 3.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 1.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 6.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 3.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 12.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 0.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.4 | 3.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 7.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 4.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 2.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.4 | 4.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 3.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 9.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 2.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 9.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 2.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 2.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.4 | 1.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 6.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 4.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 3.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 2.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 5.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 1.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 0.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.3 | 3.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 7.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 6.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 3.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 2.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 3.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 2.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 3.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 3.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 5.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 1.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 1.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 2.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 1.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 4.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 1.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 2.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 34.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 2.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 5.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 9.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 4.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 1.9 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 0.5 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 5.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.2 | 6.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 1.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 2.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 2.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 5.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 5.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 0.2 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.2 | 2.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 12.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 12.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.7 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 4.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 3.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 14.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 1.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 2.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 5.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 2.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 8.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 12.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 5.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 4.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 3.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 5.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 1.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.2 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 1.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |